David Sinclair: Living Longer is the Easy Part - The Behavioral, Ethical and Leadership Challenges | EDGE 2026
Thriving and Well-Being
•
12-Feb-2026
At EDGE 2026 in Sydney, David A. Sinclair explores the scientific, economic and societal implications of longevity research. Moving beyond the idea of simply extending lifespan, he reframes aging as a treatable biological process and outlines how targeting aging itself could delay or prevent multiple diseases simultaneously.
Drawing on decades of research, Sinclair presents evidence that aging can be reversed in animal models and discusses how advances in epigenetics and AI-driven drug discovery are accelerating the path toward human clinical applications. The session challenges leaders to rethink medicine, productivity and economic growth in a world where lifespan and healthspan may soon be programmable.
KEY TAKEAWAYS
• Extending healthspan, not just lifespan, will redefine medicine, productivity and leadership planning
• Aging is positioned as a treatable biological process rather than an inevitable decline
• Longevity breakthroughs could generate multi-trillion-dollar economic impact
Up Next in Thriving and Well-Being
-
Milo Wilkinson: Cognitive Alchemy - T...
In this high-energy session at EDGE 2026 in Sydney, Milo Wilkinson explores how primal neurological wiring shapes executive performance, decision-making, and resilience.
Drawing from neuroscience, behavioral science, and real-world case studies, Wilkinson explains how negative bias, cognitive lo...
-
Neha Sangwan: From Burnout to Boundar...
In this high-impact session at EDGE 2026 in Sydney, Neha Sangwan reframes burnout not as weakness, but as a systemic signal leaders must learn to interpret early.
Drawing on research, medical experience, and executive coaching, Sangwan introduces a practical framework built around “me, we, world...
-
Tiffany Vora: Longevity & the Future ...
In this forward-looking session at EDGE 2026 in Sydney, Tiffany Vora challenges leaders to rethink aging, healthspan, and lifespan through the lens of biotechnology and exponential technologies.
Drawing on advances in gene editing, immunotherapy, AI-enabled health monitoring, and the emerging sc...
